Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Savara Inc.
< Previous
1
2
Next >
Savara Announces New Employment Inducement Grant
August 16, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2024
August 15, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Reports Second Quarter 2024 Financial Results and Provides Business Update
August 12, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
June 28, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces Molgramostim Nebulizer Solution (Molgramostim) Achieved Statistical Significance for Primary Endpoint and Multiple Secondary Endpoints in IMPALA-2, a Pivotal Phase 3 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 26, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 25, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
May 19, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces New Employment Inducement Grant
May 16, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at the Citizens JMP Life Sciences Conference
May 07, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
April 08, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces New Employment Inducement Grant
March 22, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
March 07, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
March 06, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces New Employment Inducement Grant
February 02, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at Two Upcoming Healthcare Conferences
January 31, 2024
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
December 21, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Added to the NASDAQ Biotechnology Index
December 20, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces New Employment Inducement Grant
December 15, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Reports Third Quarter Financial Results and Provides Business Update
November 09, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at the Jefferies London Healthcare Conference
November 08, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces New Employment Inducement Grant
October 06, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Reports Second Quarter Financial Results and Provides Business Update
August 10, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces New Employment Inducement Grant
August 04, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
July 13, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Added to Russell 3000® Index
June 26, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
June 26, 2023
From
Savara Inc.
Via
Business Wire
Tickers
SVRA
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.